QQ客服 官方微博 反馈留言

	BIM Deletion Polymorphism Confers Resistance to Osimertinib in EGFR T790M Lung Cancer: a Case Report and Literature Review
	Li, Xuanzong; Wang, Shijiang; Li, Butuo; Wang, Zhen; Shang, Shuheng; Shao, Yang; Sun, Xindong; Wang, Linlin
刊名	TARGETED ONCOLOGY
	2018
卷号	13期号:4页码:517-523
DOI	10.1007/s11523-018-0573-2
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4580672
专题	山东大学
作者单位	1.Univ Jinan, Shandong Acad Med Sci, Sch Med & Life Sci, Jinan, Shandong, Peoples R China. 2.[Li, Xuanzong 3.Wang, Shijiang 4.Li, Butuo 5.S
推荐引用方式 GB/T 7714	Li, Xuanzong,Wang, Shijiang,Li, Butuo,et al. BIM Deletion Polymorphism Confers Resistance to Osimertinib in EGFR T790M Lung Cancer: a Case Report and Literature Review[J]. TARGETED ONCOLOGY,2018,13(4):517-523.
APA	Li, Xuanzong.,Wang, Shijiang.,Li, Butuo.,Wang, Zhen.,Shang, Shuheng.,...&Wang, Linlin.(2018).BIM Deletion Polymorphism Confers Resistance to Osimertinib in EGFR T790M Lung Cancer: a Case Report and Literature Review.TARGETED ONCOLOGY,13(4),517-523.
MLA	Li, Xuanzong,et al."BIM Deletion Polymorphism Confers Resistance to Osimertinib in EGFR T790M Lung Cancer: a Case Report and Literature Review".TARGETED ONCOLOGY 13.4(2018):517-523.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。